Regarding the stock’s outlook, Cantor Fitzgerald analyst Andres Sheppard reiterated his ‘Neutral’ rating on Lucid, ...

Penserra Capital Management significantly reduced its stake in Vertex Pharmaceuticals, dropping 81% of its shares in the ...

Trump’s pick to lead the NOAA, Neil Jacobs, was chief atmospheric scientist for Panasonic Weather Solutions and is a ...

Fintel reports that on July 11, 2025, Cantor Fitzgerald initiated coverage of Innoviva (NasdaqGS:INVA) with a Overweight ...

Fintel reports that on July 11, 2025, Cantor Fitzgerald initiated coverage of Tvardi Therapeutics (NasdaqCM:TVRD) with a Overweight recommendation. Analyst Price Forecast Suggests 96.77% Upside As of ...

Special purpose acquisition company Trailblazer Acquisition has filed to go public in a $200 million initial public offering. The blank-check company said in a filing with the Securities and Exchange ...

Harrow (NASDAQ:HROW) stock gains as Cantor Fitzgerald gives an Overweight rating for the company, citing a conservative outlook. Read more here.

AbbVie’s projected 2025 earnings just got trimmed by Cantor Fitzgerald, slicing estimates from $12.31 per share to $11.84.

NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES/ BRISBANE, Australia, July 11, 2025 /CNW/ - Graphene Manufacturing Group Ltd. (TSXV: GMG) OTCQX: GMGMF) (" GMG " or ...

Cantor Equity Partners, Inc. (“CEP”) (Nasdaq: CEP), a special-purpose acquisition company sponsored by an affiliate of Cantor Fitzgerald, and Twenty One Capital, Inc. (“Twenty One”), a newly formed ...

Centene Corporation (NYSE: CNC) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On July 2, Cantor ...

The company may sell up to $2 billion in stock through Cantor Fitzgerald and ThinkEquity in flexible at-the-market deals, according to a Wednesday filing.